InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: drumstick57 post# 125915

Tuesday, 06/04/2013 10:27:01 AM

Tuesday, June 04, 2013 10:27:01 AM

Post# of 346056

How do you know dr's take kick backs ..



Pfizer does actually "report" some of the payouts such as these... but important to note: these what about the ones that are not "found"

70 Disclosures Found for Payments in North Dakota from Pfizer

"If your provider is listed, it’s because a drug company reported paying him or her for promotional activities, meals, travel, educational items, consulting or research. Such payments are legal, but research has shown that drug-company marketing can influence what a doctor prescribes."

https://projects.propublica.org/docdollars/payments/company/pfizer/state/35?method_arg=35&page=2
------------------------------------------------------------------

I'll just pick the first one on the list "Odyssey Research..."

"Odyssey Research is a clinical Trial Management Organization (TMO) headquarted in Bismarck, ND. Odyssey Research manages clinical research trials for pharmaceutical companies and CROs by partnering with independent physician investigators within their practices. The Odyssey Research mission is to provide clinical research trial opportunities to community based physicians and patients."

http://www.linkedin.com/company/odyssey-research-services
------------------------------------------------------------------

Pfizer has an oncology top dog .. and if anyone knows about a possible partnership... it will need to go through Dr. Richard D. Connell: ... interesting ..

Dr. Connell joined Pfizer in 1999 as Director of Cancer Chemistry. He was an inventor on one of the two key patents for the drug now known as Tarceva®, which is has been shown to improve overall survival in advanced non-small cell lung cancer and advanced pancreatic cancer. He then became Pfizer’s Executive Director of Research operations and, next, the Vice President of External Research Solutions Center of Excellence (ERS). In 2011, Dr. Connell moved to Shanghai for a one- year assignment to help Pfizer establish the Anti-infective Research Unit. He returned to the States in early 2012 and continues to lead ERS and manage Pfizer’s network of research partners around the globe.

http://graduateschool.nd.edu/news/39625-richard-d-connell-ph-d-1989-chemistry-named-the-graduate-schools-2013-distinguished-alumnus/
-----------------------------------------------------------------

I lost track... we were talking about "payouts".. oh, pfizer payouts to Doctors.... ND... I wonder where it ends

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News